SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-023285
Filing Date
2024-07-23
Accepted
2024-07-23 16:33:52
Documents
14
Period of Report
2024-07-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K alim20240723_8k.htm   iXBRL 8-K 26918
  Complete submission text file 0001437749-24-023285.txt   159337

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alim-20240717.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alim-20240717_def.xml EX-101.DEF 11442
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alim-20240717_lab.xml EX-101.LAB 15348
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alim-20240717_pre.xml EX-101.PRE 11602
16 EXTRACTED XBRL INSTANCE DOCUMENT alim20240723_8k_htm.xml XML 2872
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34703 | Film No.: 241134861
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)